News & Insights | Clinical Insider

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

JPM 2025: ICON, PPD talk trial sector volatility; NVIDA outlines IQVIA accord

Fine-tuned AI could aid trial design and transparency compliance, study says

$165m PE investment sets Caidya on M&A trail

Inside AstraZeneca's DISCLOSE process

Sponsor trial spending surge will coincide with supplier streamlining

Proposed UK trial rules would increase clinical trial transparency

Complying with trial registries and other global disclosure reporting requirements an ongoing challenge

FDA: Tissue biopsies used in trials must be justified

AI/ML current status of clinical trial implementation

Clinical trial plain language processes can mean authoring with the end in mind

Veeda rebrands with eye on innovator drug trials

EMA changes transparency rules to emphasize patient and trial staff privacy

Upcoming ICH GCP guide will increase use of risk-based monitoring, says ACRO

Streamlining first-in-human trials with IRT systems

Lessons learned from implementing eConsent to IRT integration

Patient centricity, market access, and private equity fueled CRO M&A in 2024

Private equity firm sets out expansion plan for EMAS Pharma

Carta Healthcare buys trial data abstraction counterpart Realyze Intelligence

hVIVO contracted for $11.5m Phase IIb RSV antiviral trial

Swiss authorities clarify safety rules for first-in-human trials

Quick Links